These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 2631420)
1. [The stability of the oxime Hi-6 in eyedrops]. Macić I; Antunović M Vojnosanit Pregl; 1989; 46(6):415-9. PubMed ID: 2631420 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova J; Musilek K; Kuca K Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821 [TBL] [Abstract][Full Text] [Related]
3. Study on the stability of the oxime HI 6 in aqueous solution. Eyer P; Hagedorn I; Ladstetter B Arch Toxicol; 1988; 62(2-3):224-6. PubMed ID: 3196158 [TBL] [Abstract][Full Text] [Related]
4. Comparative protective effects of HI-6 and MMB-4 against organophosphorous nerve agent poisoning. Lundy PM; Hamilton MG; Sawyer TW; Mikler J Toxicology; 2011 Jul; 285(3):90-6. PubMed ID: 21524678 [TBL] [Abstract][Full Text] [Related]
5. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats. Kassa J; Misik J; Karasova JZ Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919 [TBL] [Abstract][Full Text] [Related]
6. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice. Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406 [TBL] [Abstract][Full Text] [Related]
7. A comparison of the potency of newly developed oximes (K074, K075) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J; Karasova J Toxicology; 2007 Jan; 229(1-2):136-44. PubMed ID: 17141392 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the neuroprotective efficacy of newly developed oximes (K206, K269) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats. Kassa J; Karasova JZ; Bajgar J; Tesarova S; Kuca K; Musilek K Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):228-35. PubMed ID: 19143747 [TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain. Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679 [TBL] [Abstract][Full Text] [Related]
10. The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-poisoned rats. Kassa J; Karasova J; Vasina L J Appl Toxicol; 2007; 27(6):621-30. PubMed ID: 17685413 [TBL] [Abstract][Full Text] [Related]
11. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats]. Kassa J; Bajgar J Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233 [TBL] [Abstract][Full Text] [Related]
12. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Jokanović M; Stojiljković MP Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842 [TBL] [Abstract][Full Text] [Related]
13. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice. Kassa J; Karasova JZ; Sepsova V; Caisberger F Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):30-4. PubMed ID: 21235715 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. Kassa J; Kunesova G J Appl Toxicol; 2006; 26(4):309-16. PubMed ID: 16552727 [TBL] [Abstract][Full Text] [Related]
15. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice. Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085 [TBL] [Abstract][Full Text] [Related]
16. Estimation of oxime efficacy in nerve agent poisoning: a kinetic approach. Worek F; Szinicz L; Thiermann H Chem Biol Interact; 2005 Dec; 157-158():349-52. PubMed ID: 16266695 [TBL] [Abstract][Full Text] [Related]
17. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing. Bartosova L; Kuca K; Jun D; Kunesova G Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932 [TBL] [Abstract][Full Text] [Related]
18. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice. Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model. Aurbek N; Thiermann H; Szinicz L; Worek F Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808 [TBL] [Abstract][Full Text] [Related]
20. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice. Kassa J; Karasova JZ; Caisberger F; Bajgar J Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]